BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile
..
 

MedImmune 

One MedImmune Way

Gaithersburg  Maryland  20878  U.S.A.
Phone: 301-398-0000 Fax: 301-398-9000


SEARCH JOBS

MedImmune is the worldwide biologics business for the AstraZeneca Group. The company has approximately 3,000 employees worldwide and is headquartered in Gaithersburg, Maryland with facilities in Pennsylvania, California, Kentucky, the United Kingdom, and the Netherlands. UK facilities include vaccine manufacturing operations in Speke and antibody discovery and research laboratories in Cambridge.

With two marketed products and an advancing pipeline of promising candidates in the areas of infection, oncology, respiratory disease and inflammation, cardiovascular/gastrointestinal disease and neuroscience, MedImmune strives to provide better medicines to patients, new medical options for physicians and rewarding careers to employees.

 Key Statistics


Email:
Ownership: Public

Web Site: MedImmune
Employees: 3,000
Symbol: AZN
 



Industry
Biotechnology






 Company News
Like MedImmune (AZN), GlaxoSmithKline (GSK) Takes Aim At Cancer In MD Anderson Cancer Center's Moon Shots Program 4/9/2014 10:46:34 AM    More...
MedImmune (AZN), MD Anderson Cancer Center Agree To Launch Moon Shot At Cancer 3/19/2014 8:38:50 AM    More...
MedImmune (AZN) Deal Exposes Early-Stage University of California, San Francisco (UCSF) Drugs 2/12/2014 7:42:01 AM    More...
Sucampo Pharmaceuticals, Inc. (SCMP) Taps Ex-MedImmune (AZN) President For Top Post 2/11/2014 7:24:09 AM    More...
MedImmune (AZN), Immunocore Limited Forges Cancer Deal Worth $320 Million 1/8/2014 7:55:34 AM    More...
BHI Elects MedImmune (AZN)'s Reg Seeto, M.D. to Board of Directors 12/19/2013 6:53:59 AM    More...
AstraZeneca PLC (AZN)'s MedImmune (AZN) Takes Over Spirogen Ltd. for Up to $400 Million to Bolster Oncolology Portfolio 10/15/2013 7:54:15 AM    More...
AstraZeneca PLC (AZN)'s MedImmune (AZN) Gobbles Up Amplimmune for Up to $500 Million 8/26/2013 7:25:10 AM    More...
Kolltan Pharmaceuticals Inc. Enters into License and Option Agreement With MedImmune (AZN) 7/29/2013 9:29:38 AM    More...
MedImmune (AZN)'s FluMist® Quadrivalent (Influenza Vaccine Live, Intranasal), Four-Strain, Nasal-Spray Flu Vaccine, Ships for 2013-2014 Influenza Season 7/29/2013 8:26:48 AM    More...
12345678910...

//-->